Sarah Boyce

Director; Director, President and CEO · 5 filings · Latest: Sep 18, 2026

Atrium Therapeutics, Inc.

Avidity Biosciences, Inc.

Contineum Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
RNA	Sarah Boyce	Director, President and CEO	Jan 21, 2026	Sale	$72.45	14,387	$1.0M	269,007	Jan 23 10:34 PM
RNA	SARAH BOYCE	—	Sep 5, 2025	Proposed Sale	$48.47	50,000	$2.4M	—	Sep 5 8:25 PM
RNA	SARAH BOYCE	—	Aug 28, 2025	Proposed Sale	$47.82	25,000	$1.2M	—	Aug 28 8:21 PM